A pill from AstraZeneca failed to improve outcomes in closely watched breast cancer study, a result that could limit the use ...
U.S. officials declare an end to record-setting cyclospora outbreak, but its origin is still unknown
The largest cyclospora food poisoning outbreak in U.S. history is over, U.S. health officials said, but questions remain over ...
A late-stage clinical trial found that, when combined with an SMN2-targeting drug, Isembyld caused young patients’ motor ...
A newly approved AI tool can scan EKGs for severe heart attacks and, the company says, for rarer patterns indicating blocked ...
New Medicaid rules use allow use of tiers to determine work exemptions. Advocates fear complex guidelines could cause ...
Platinum chemotherapy's long-term effects, surprising heart failure drug failures, and more biotech news from The Readout ...
About four dozen children who attended a community party in August 2025 later developed skin and soft tissue lesions and ...
Novartis investors are stepping up scrutiny of the company's dealmaking after setbacks to drugs it acquired through mergers ...
Angus reports on the basic research, clinical science, and drug development that may transform survival and quality of life for patients, as well as developments affecting the cancer community. You ...
An E.U. AG recommended annulling part of a directive that requires drugmakers to finance 80% of the costs of wastewater ...
Pharmalittle: We’re reading about a Novartis investor seeking a shake-up, a Gilead setback, and more
A major Novartis shareholder has called for a shake-up of the drugmaker's board after its shares suffered a record fall ...
The Trump administration is promising to send $500 refund checks to nearly 1 million people with Affordable Care Act health ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results